Would you like to learn more about new and future treatments?
Our Education and Training Manager, Helen Mee, talks about our upcoming event in Glasgow and explains why you should join us
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Our Education and Training Manager, Helen Mee, talks about our upcoming event in Glasgow and explains why you should join us
Should obinutuzumab be used as part of the first-line treatment of follicular lymphoma or should we stick with rituximab?
Our Senior Medical Writer, Dr Becky Salisbury, talks about some of the hot topics raised at the recent British Society of Haematology meeting.
Our Senior Medical Writer, Dr Becky Salisbury, talks about some of the hot topics raised at the recent British Society of Haematology meeting.
Promising results for new antibody treatment for B-cell lymphomas in ongoing Hu5F9-G4 clinical trial
Lymphoma Canada is seeking the views of peripheral T-cell lymphoma patients who have experience of pralatrexate or belinostat.
Share your experiences in new study from Opinion Health, a UK healthcare research firm.
Lymphoma Canada is seeking the views of DLBCL patients who have had CAR-T Cell therapy.
Becky, our senior medical writer, looks at new approaches for high-grade non-Hodgkin lymphoma, discussed at the ASH meeting in December.
Becky, our senior medical writer, looks at some of the questions raised about maintenance for follicular lymphoma at the post-ASH meeting.